Eleuthero: benefits, dosage, contraindications

Mis à jour le

Eleutherococcus (Eleutherococcus senticosus), also known as Siberian ginseng, is a plant cultivated mainly in China, Korea, Japan and Siberia. It is a spiny shrub 2 to 3 meters tall. It has long stems with palmate leaves and produces small flowers gathered in globular umbels. The male flowers are violet while the female flowers are yellow. The fruits of Eleutherococcus are black berries. Its roots are used therapeutically and — more rarely — the berries. Eleutherococcus has been used for more than 2,000 years in traditional Chinese medicine, where it is called ci wu jia. It was used to prevent colds and flu and to increase vitality and energy. More recently, it has been used by Russian cosmonauts to improve alertness and energy and to help adapt to the stresses of life in space. Its roots contain eleutherosides responsible for its adaptogenic properties, meaning they help the body adapt to stress and restore the normal balance of its functions. Other bioactive components include isofraxidin, syringin (a phenylpropanoid glucoside) and nutrients. The nutrients include magnesium, manganese, and vitamins A and E. Eleutherococcus is reputed to stimulate the immune system, to improve resistance to stress and to boost physical performance during difficult periods. The EMA recommends it as a traditional herbal medicinal product for the symptoms of asthenia such as fatigue and weakness.

Other name(s) 

Siberian ginseng, Ciwujia

Scientific name(s)

Eleutherococcus senticosus, Acanthopanax senticosus, Acanthopanacis senticosi

Family or group: 

Plants

Active ingredients:

Coumarins

Saponins

Lignans

Eleutherosides


Indications

Scoring methodology

EFSA approval.

Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with consistently positive conclusions for the indication.
Several randomized, double-blind, controlled clinical trials (> 2), including a significant number of patients (>100), with positive conclusions for the indication.
One or more randomized studies, or several cohorts or epidemiological studies, with positive conclusions for the indication.
Clinical studies exist but are uncontrolled, with conclusions that may be positive or conflicting.
No clinical studies to date that can demonstrate the indication.


Herpes
✪✪✪✪✪

A clinical study conducted in men with recurrent genital herpes infections shows that taking a specific Eleutherococcus extract (Elagen), standardized to contain 0.3% eleutherosides, reduces the frequency, severity and duration of outbreaks. More recently, the Elagen formulation contains at least 2 g of dried root equivalent in each capsule of concentrated Eleutherococcus Senticosus extract standardized to approximately 0.4% eleutheroside B and 0.5% eleutheroside E.

Posologie

posologieOral: root

posologie2000 mg

formulationstandardized extract


Fatigue
✪✪✪✪✪

Eleutherococcus is indicated in cases of decreased mental and physical capacities such as weakness, exhaustion, fatigue and loss of concentration, as well as during convalescence, according to ESCOP (European Scientific Cooperative on Phytotherapy) and the EMA (European Medicines Agency). Several clinical studies support these indications. A randomized, double-blind, placebo-controlled trial of 300 mg/day (dry extract) for 8 weeks evaluated health-related quality of life scores in 20 elderly people. Improvements were observed in social functioning after 4 weeks of treatment, but did not persist to 8 weeks. It appears that improvements diminish with continued use, which may help explain the practice of giving eleutherococcus for 6 weeks with a break of 2 weeks before restarting. In another randomized, placebo-controlled clinical trial conducted in 76 people with chronic fatigue, no statistically significant reduction in fatigue was demonstrated; however, interesting results were noted in certain subgroups. For example, among subjects with moderate fatigue, a significant improvement was observed after 2 months in those who took eleutherococcus compared with those on placebo. The product used provided 2.24 mg of eleutherosides from 2 g of extract consumed in total per day. The ability of Siberian ginseng to increase levels of norepinephrine, serotonin, epinephrine and cortisol provides a theoretical basis for its use in fatigue. However, controlled studies remain limited.

Posologie

posologieOral use: root

posologie300 - 2000 mg

duration6 - weeks

formulationalcoholic extract, dry extract


Cold
✪✪✪✪✪

Some clinical research shows that oral administration of a combination containing eleuthero and andrographis (Kan Jang) improves cold symptoms when started within 72 hours of symptom onset. Some symptoms may improve after 2 days of treatment; however, it usually takes 4 to 5 days of treatment to obtain maximal symptom relief. The combination of eleuthero and andrographis relieves cold symptoms better than echinacea or placebo in children, according to studies.

Posologie

posologieOral use: root

posologie400 - 1200 mg

duration5 - days

formulationstandardized extract, dry extract


Synergies


Type 2 diabetes
✪✪✪✪✪

A clinical study conducted in adults with type 2 diabetes shows that taking a specific Eleutherococcus extract, standardized to contain eleutherosides E and B at 1.12%, at a dose of 480 mg per day for 3 months, reduces fasting and postprandial blood glucose levels, lowers glycated hemoglobin (HbA1c), and decreases triglyceride and total cholesterol levels compared with placebo.

Posologie

posologieOral: root

posologie480 mg

duration3 months

formulationstandardized extract


Stress
✪✪✪✪✪

In a randomized, controlled study of 144 participants suffering from asthenia and reduced work capacity related to chronic stress, eleuthero improved parameters over time and a significant difference was found in mental fatigue and agitation, in favor of eleuthero supplementation, compared with a 2-day professional stress management training. A 6-week, placebo-controlled study examined the effects of an ethanolic extract of eleuthero (8 ml/day, equivalent to 4 g/day of dried root) in athletes. In the study, treatment resulted in an increase in cortisol levels, which may be consistent with animal research suggesting a stress threshold below which eleuthero increases the stress response and above which it decreases the stress response. Finally, a small clinical study conducted in healthy women aged 20 to 68 who had experienced prolonged stress shows that taking a single 270 mg dose of a formulation (ADAPT-232) containing eleuthero, rhodiola, and schisandra improves attention as well as cognitive speed and accuracy compared with placebo.

Posologie

posologieOral: root

posologie120 mg

duration6 - weeks

formulationalcoholic extract, ADAPT-232, dry extract


Synergies


Improve adaptive capacity
✪✪✪✪✪

Eleutherococcus is classified as a recognized adaptogen for its ability to improve the stress response. Studies have shown that Eleutherococcus acts primarily on the hypothalamic-pituitary-adrenal (HPA) axis, modulating the production of neurotransmitters and hormones such as cortisol and catecholamines. This helps prevent exhaustion related to chronic stress and maintain an effective adaptive response.nnEleutherococcus appears to tune the stress response according to an individual's level, increasing resistance in moderate stress situations while attenuating excessive stress reactions. It has also been shown to have anxiolytic and antioxidant properties, making it an effective supplement to improve mental and physical endurance.nn

Posologie

posologieBy mouth: root

posologie240 mg

duration4 weeks

formulationstandardized extract, dry extract


Properties


Adaptogenic

full-leaffull-leaffull-leaffull-leaf

Siberian ginseng appears to modify the levels of various neurotransmitters and hormones involved in the stress response, primarily at the level of the HPA axis (hypothalamic-pituitary-adrenal axis). Various mechanisms have been proposed, including inhibition of catechol-O-methyltransferase, which inactivates catecholamines. As a result, catecholamine levels are not depleted, and the release of new catecholamines by nerve synapses decreases. Theoretically, this effect reduces the risk of exhaustion of the body's adaptive responses to stress. Additionally, eleutherosides have been shown to improve carbohydrate metabolism and energy supply and to increase the synthesis of proteins and nucleic acids, although the direct molecular targets responsible for this adaptive response remain unknown. It has also been reported in vitro that eleutherosides bind to receptor sites for progestogens, estrogens, mineralocorticoids, and glucocorticoids and can therefore theoretically exert many important pharmacological actions during the body's stress response. Thus, the overall action of the herb has been described as "adaptogenic". Although the mechanism of action responsible is still not clear, several theories have been proposed to explain the effect of Siberian ginseng on allostatic systems. Indeed, research has shown that Siberian ginseng can act in different ways, depending on the stage of the stress response, to support the 'stress system'. Research suggests that there is a stress threshold below which the herb increases the stress response and above which it decreases the stress response.

Usages associés

Stress, Fatigue, Improve adaptability

Neurological

full-leaffull-leaffull-leafempty-leaf

Eleutherococcus protects neurons and inhibits apoptosis of brain cells. In animal research, an aqueous extract of Eleutherococcus inhibited inflammation and microglial activation in cerebral ischemia. In cultured rat cortical neurons, Eleutherococcus extracts were shown to have protective effects on neurite regeneration and synapse reconstruction in cultured rat cortical neurons damaged by beta-amyloid. This effect would be due, at least in part, to eleutheroside B. In mice, eleutheroside E prevented the behavioral disturbances induced by sleep deprivation, notably reductions in latency to enter a dark chamber and in locomotion, as well as the increase in monoamines (serotonin and dopamine) in the hippocampus, which suggests that this component of Eleutherococcus could be valuable for stress associated with chronic insomnia.

Usages associés

Stress

Cardiovascular

full-leaffull-leafempty-leafempty-leaf

Eleutherococcus, when administered orally to rats (at a dose of 1 ml/kg for 8 days), showed protective effects on the heart. These benefits, which include protection against cardiac rhythm disturbances (antiarrhythmic effects), appear to be due to an increase in the levels of the body's natural opioid peptides. In laboratory studies, Eleutherococcus also exhibits a vasorelaxant effect. This effect could be caused by several mechanisms, such as increased production of nitric oxide (a gas that relaxes blood vessels), activation of muscarinic receptors (receptors involved in controlling the nervous system), or by influencing certain channels in cells that regulate the passage of potassium ions. In a study conducted on cultured neonatal rat cardiac cells, a specific component of Eleutherococcus, acanthopanax senticoside B (which is part of the plant's saponins), protected these cells against damage caused by oxidative stress. It did so by reducing lipid peroxidation (a type of cellular damage) and by increasing the activity of the body's antioxidant defense mechanisms.


Hypoglycemic

full-leaffull-leafempty-leafempty-leaf

Eleutherococcus (Siberian ginseng) has hypoglycemic properties observed in laboratory (in vitro) and animal (in vivo) studies. - It reduces glucose absorption by inhibiting an enzyme called alpha-glucosidase, thereby limiting the amount of glucose that enters the bloodstream. - Eleutherosides, components of Eleutherococcus, particularly eleutherosides E and B, allow glucose to enter cells without relying on insulin, the hormone normally required for this process. - Eleutherococcus can counteract obstacles to glucose transfer caused by certain proteins (β-lipoproteins) in cell membranes. - Syringin, a constituent, improves glucose utilization and may lower blood glucose levels. This may be due to increased release of acetylcholine, which stimulates insulin release, or by promoting beta-endorphin secretion, resulting in reduced blood glucose.

Usages associés

Type 2 diabetes

Immunomodulator

full-leaffull-leafempty-leafempty-leaf

Eleutherococcus extract has demonstrated immunomodulatory effects, including increased cellular and humoral activity, activation and proliferation of immunocompetent cells, and stimulation and inhibition of cytokine synthesis, in human, animal, and in vitro research. According to a review, immunomodulatory polysaccharides or saponins isolated from Eleutherococcus stimulated macrophages, promoted antibody formation, activated complement, and increased T lymphocyte proliferation. In rabbits, Eleutherococcus extract produced a sustained immunostimulant effect and increased phagocytic activity. In vitro, syringin, a constituent of Eleutherococcus root, stimulated phagocytosis by rat blood macrophages (immune system cells that help fight infections). Also, Eleutherococcus reduced the occurrence of allergic reactions. Histamine release from rat peritoneal mast cells, as well as secretion of tumor necrosis factor (TNF)-alpha and interleukin (IL)-6, were also inhibited. Similar results were observed in other animal studies, suggesting an anti-allergic effect of Eleutherococcus.

Usages associés

Herpes, respiratory infections

Antiviral

full-leafempty-leafempty-leafempty-leaf

In vitro, a liquid extract of Eleutherococcus inhibited productive replication of RNA viruses, human rhinovirus, respiratory syncytial virus, and influenza A virus. However, it does not appear to affect DNA viruses such as adenovirus or herpes simplex virus type 1.

Usages associés

Common cold, herpes, respiratory infections


Safe dosage

Adults aged 17 and over: 200 mg - 1000 mg (dry extract)

- Root decoction: 0.5 to 4 g of dried roots in 150 ml of boiling water, at a rate of 1 to 2 cups per day. - Mother tincture: up to 4 ml per day in 2 or 3 doses - Capsules or tablets: up to 1 g of root powder per day in 2 or 3 doses, which corresponds to 200 mg of dry extract per capsule. Extracts are generally standardized to provide 0.1% eleutheroside E (syringaresinol diglucoside) and 0.5% eleutheroside B (syringin). It is recommended not to exceed 6 weeks.


Interactions

Médicaments

Antiplatelet agents/Anticoagulants: moderate interaction

Eleuthero has anticoagulant effects; theoretically, taking eleuthero alongside anticoagulant therapy increases the risk of bleeding.

Antidiabetic: moderate interaction

In healthy individuals, supplementation with eleuthero increases postprandial blood glucose but has a hypoglycemic effect in patients with diabetes. When combined with antidiabetic medications, eleuthero supplementation could interfere with treatment.

Central nervous system depressants: minor interaction

Some studies report the sedative properties of eleuthero, so its concomitant use with sedatives could have additive effects and side effects.

Cytochrome P450 substrate: minor interaction

Eleuthero supplementation appears to interact with medications that are cytochrome P450 substrates. By inhibiting cytochromes P450 1A2, 2C9, 2D6 and 3A4, taking eleuthero interferes with the metabolism of substances broken down by cytochrome P450 enzymes. Examples: Clozapine, Theophylline, Diclofenac, Tamoxifen, Metoprolol, Statins, Cyclosporine and others.

Immunosuppressant: minor interaction

Due to its immune-stimulating properties, eleuthero interferes with immunosuppressive treatments.

Plantes ou autres actifs

Antiplatelet agents/anticoagulants: moderate interaction

Eleuthero has anticoagulant effects; theoretically, eleuthero supplementation alongside an anticoagulant treatment increases the risk of bleeding.

Sedative: minor interaction

Some studies report the sedative properties of eleuthero, so its concomitant use with sedatives could have additive effects and side effects. Example: Ashwagandha, lemon balm, hawthorn, chamomile and others.


Precautions

Child aged 12 to 17 years: use with caution

Eleuthero supplementation is possible in adolescents aged 12 to 16 years but dosages are not available.

Pregnant women: avoid

Use is not recommended due to a lack of reliable and sufficient information.

Breastfeeding women: avoid

Use is not recommended due to a lack of reliable and sufficient information.

Children up to 12 years: avoid

Use in children under 12 years has not been established due to the lack of adequate data.


Contraindications

Hypertension: contraindicated

Eleuthero is contraindicated in people whose blood pressure exceeds 180/90. Eleuthero may potentially exacerbate hypertension.

Cardiovascular disease: contraindicated

Eleuthero can cause palpitations, tachycardia and hypertension and should be used with caution in patients with cardiovascular disorders (for example, atherosclerotic or rheumatic heart disease). It can also cause headaches and pericardial pain in patients with rheumatic heart disease.